Oxigene Inc (NASDAQ:OXGN)

CAPS Rating: 3 out of 5

A biotechnology company developing novel small-molecule therapeutics to treat cancer and eye diseases.

Results 1 - 16 of 16

Recs

0
Member Avatar oscillation (41.05) Submitted: 4/2/2015 10:14:36 AM : Outperform Start Price: $1.43 OXGN Score: -54.08

nev

Recs

0
Member Avatar joienpaix (< 20) Submitted: 3/18/2015 7:32:31 PM : Outperform Start Price: $1.60 OXGN Score: -57.27

May take a while:

http://seekingalpha.com/symbol/OXGN

Recs

0
Member Avatar Deepvaluestocks (< 20) Submitted: 12/28/2014 4:43:42 PM : Outperform Start Price: $1.63 OXGN Score: -58.85

Considering the strong balance sheet, I believe that the current EV of about $5 million undervalues fosbretabulin's potential, leading me to place a buy recommendation on the stock.

Recs

1
Member Avatar Crystalball (94.43) Submitted: 3/21/2014 10:32:31 AM : Outperform Start Price: $3.79 OXGN Score: -92.75

Zybrestat, when used in combination with Roche's (RHHBY) Avastin, delayed the re-growth of ovarian cancer, in recent phase II study. The potential for significant upside exists on this one, and management obvious believes in itself holding a large insider position.

Recs

0
Member Avatar BioInvestor2013 (< 20) Submitted: 3/15/2014 10:09:45 AM : Outperform Start Price: $4.22 OXGN Score: -95.63

http://bioinvestor204.blogspot.de

Recs

3
Member Avatar BACnumber1 (< 20) Submitted: 11/9/2011 4:13:45 AM : Underperform Start Price: $13.68 OXGN Score: +160.41

Sadly I own this company.....

Recs

1
Member Avatar BamaBoyT (69.93) Submitted: 9/15/2011 9:35:05 AM : Outperform Start Price: $16.44 OXGN Score: -167.59

This will be a hot stock to day trade. Will be around 5 dollars in near future.

Recs

0
Member Avatar kanol (< 20) Submitted: 5/11/2011 10:00:19 AM : Outperform Start Price: $54.34 OXGN Score: -151.36

UP UP UP EXPLOSION!

Recs

3
Member Avatar kampaakampaa (< 20) Submitted: 6/17/2010 9:51:02 AM : Underperform Start Price: $141.58 OXGN Score: +183.58

New financing and need more Falcon data

Recs

1
Member Avatar armyinu (< 20) Submitted: 6/1/2009 2:40:50 PM : Outperform Start Price: $564.00 OXGN Score: -219.67

I see it that this drud is going to finish ahead and that the FDA will aprove it and this stock is going to sky rocket if i where you I would buy buy buy

Recs

1
Member Avatar suave1007 (< 20) Submitted: 8/14/2007 6:29:40 PM : Outperform Start Price: $856.80 OXGN Score: -152.11

Science: Destroys in minutes ALL blood vessels of tumor!while preserving ALL other healthy cells!! NO side effects:
http://www.wsw.com/webcast/rrshq10/oxgn/3__Slide16.JPG
OXGN SAFETY:Lazard pres.

Seasoned and creditentialled Mgt Team under Dr. Richard Chin who guided two of Genentechs current blockbusters: Avastin & Lucentis. In his 3rd month as CEO downsized co 33% and focused strategy of timely executions.

Poised for Success is OXGN's Mantra.

$4+mln of open mkt purchases by mgt team! $65K during Aug 5-10 by newest director Fickling.

Indeed rare to find a $100 mln Mkt Cap. oncology play IN Phase THREE!

Recs

2
Member Avatar jwfoster (29.12) Submitted: 5/5/2007 10:34:23 PM : Outperform Start Price: $1,137.60 OXGN Score: -146.96

I am not smart enough to figure out which drugs will be good or bad. What will pass phase III trials, etc. But, what I do know is that when a biotech stock has tons of insiders who know the drug business buying up shares like crazy and have a lung cancer product that they can charge whatever they would want, it is worthy of buying.

This is not just a caps pick but, one of my larger personal holdings.

Recs

0
Member Avatar oj1480 (< 20) Submitted: 2/5/2007 10:50:03 AM : Outperform Start Price: $1,063.20 OXGN Score: -151.30

i heard good news about this one.

Recs

0
Member Avatar TechnicalTommy (54.94) Submitted: 1/17/2007 4:29:07 AM : Outperform Start Price: $1,130.40 OXGN Score: -153.25

Favorable news from pipeline in December. Things have finally settled down now.

Recs

0
Member Avatar alyssakh (< 20) Submitted: 11/25/2006 9:48:23 PM : Outperform Start Price: $1,080.00 OXGN Score: -156.14

Clinical trials almost done.

Recs

0
Member Avatar guy1818181818 (< 20) Submitted: 9/25/2006 8:17:30 PM : Outperform Start Price: $950.40 OXGN Score: -164.35

5x potential

Results 1 - 16 of 16

Featured Broker Partners